Epigenetix
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1004 Brooks Ln, Delray Beach, Florida, 3...Phone Number
(561) 543-7569Website
www.epigenetix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Epigenetix
Epigenetix specializes in developing innovative cancer treatments, focusing on epigenetic changes to enhance precision targeting in lethal cancers. Their flagship product, EP31670 (NEO2734), is a first-in-class oral medication designed for Myelofibrosis and other malignancies, currently undergoing clinical trials at leading cancer centers. The company aims to address various myeloid malignancies, metastatic castrate-resistant prostate cancer, and other aggressive cancers with a unique dual inhibitor approach. With promising early results and a commitment to advancing cancer therapy, Epigenetix is positioned at the forefront of cancer treatment innovation.Explore more
Epigenetix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epigenetix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Epigenetix had a recent Job posting/layoffs
Product Launch: Get notified when Epigenetix launches new products
Epigenetix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Epigenetix recently announced quarterly report
Funding: Get notified immidiatlly once Epigenetix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Epigenetix is spiking on competitors!
Check if Epigenetix has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Epigenetix
Recommended Actions
Find VP level buyers at Epigenetix
Find 3 more new buyers
Compare Similar Companies to Epigenetix
Compare insights from companies similar to Epigenetix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Epigenetix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Epigenetix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Epigenetix.
Epigenetix Tech Stack
A closer look at the technologies used by Epigenetix
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epigenetix
Sign Up For FreeTo access detailed company insights
Epigenetix specializes in developing innovative cancer treatments, focusing on epigenetic changes to enhance precision targeting in lethal cancers. Their flagship product, EP31670 (NEO2734), is a first-in-class oral medication designed for Myelofibrosis and other malignancies, currently undergoing clinical trials at leading cancer centers. The comp... Read More
